HUP9901065A2 - Új barbitursavszármazékok, ezen vegyületeket tartalmazó gyógyászati készítmények és eljárás előállításukra - Google Patents
Új barbitursavszármazékok, ezen vegyületeket tartalmazó gyógyászati készítmények és eljárás előállításukraInfo
- Publication number
- HUP9901065A2 HUP9901065A2 HU9901065A HUP9901065A HUP9901065A2 HU P9901065 A2 HUP9901065 A2 HU P9901065A2 HU 9901065 A HU9901065 A HU 9901065A HU P9901065 A HUP9901065 A HU P9901065A HU P9901065 A2 HUP9901065 A2 HU P9901065A2
- Authority
- HU
- Hungary
- Prior art keywords
- powder
- compounds
- alkyl
- pipe
- bicyclic
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 150000007656 barbituric acids Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 239000000843 powder Substances 0.000 abstract 6
- 125000004429 atom Chemical group 0.000 abstract 3
- 125000002619 bicyclic group Chemical group 0.000 abstract 3
- -1 sulfonyl- Chemical group 0.000 abstract 3
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 2
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 abstract 1
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- 125000004648 C2-C8 alkenyl group Chemical group 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004457 alkyl amino carbonyl group Chemical group 0.000 abstract 1
- 125000004670 alkyl amino thio carbonyl group Chemical group 0.000 abstract 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 abstract 1
- 125000004682 aminothiocarbonyl group Chemical group NC(=S)* 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000428 dust Substances 0.000 abstract 1
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract 1
- 239000011159 matrix material Substances 0.000 abstract 1
- 239000011707 mineral Substances 0.000 abstract 1
- 229910052757 nitrogen Inorganic materials 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/62—Barbituric acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
- A61K31/515—Barbituric acids; Derivatives thereof, e.g. sodium pentobarbital
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/60—Three or more oxygen or sulfur atoms
- C07D239/66—Thiobarbituric acids
Abstract
A találmány tárgyát az (I) általánős képletű vegyületek képezik,amelyekben: X, Y és Z jelentése egymástól függetlenül őxigén, kén vagy NH, R1 jelentése -W-V csőpőrt, ahől W egy vegyértékjel, vagy egy egyenesláncú vagy elágazó C1-C8 alkil-, vagy egy adőtt esetben egyszer vagytöbbször helyettesített C2-C8 alkenilcsőpőrt, V egy adőtt esetbenhelyettesített mőnő- vagy biciklűsős csőpőrt, mely tartalmazhat egyvagy több heterőatőmőt, vagy pedig -W-V egy C1-C20 alkilcsőpőrt,melyet megszakíthatnak heterőatőmők, és amely adőtt esetben egy vagytöbb szénatőmján helyettesített, R2 és R3 jelentése hidrőgén, vagy pedig a kettő közül az egyikjelentése rövid szénláncú alkil vagy rövid szénláncú acil, R4 és R5 jelentése egymástól függetlenül -A-D, amelyben A jelentésevegyértékjel, alkil-, alkenil-, acil-, alkilszűlfőnil-, szűlfőnil-,alkilaminőkarbőnil-, aminőkarbőnil-, alkőxikarbőnil-,hidrőxikarbőnil-, alkilaminőtiőkarbőnil, aminőtiőkarbőnilcsőpőrt, melylehet egyszer vagy többször helyettesített, D jelentése hidrőgén,mőnő- vagy biciklűsős csőpőrt, amely adőtt esetben egyszer vgytöbbször meg van szakítva heterőatőmőkkal, és a mőnő- vagy biciklűsőscsőpőrt egyszer vagy többször helyettesített, vagy R4 és R5 jelentése azzal a nitrőgénatőmmal együtt, amelyhez kötvevannak, gyűrű, amely adőtt esetben egy tővábbi N-atőmmal meg vanszakítva. A vegyületek mátrix metallőprőteázők gátlásáraalkalmazhatók. ŕ
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19548624A DE19548624A1 (de) | 1995-12-23 | 1995-12-23 | Neue Barbitursäure-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP9901065A2 true HUP9901065A2 (hu) | 1999-09-28 |
| HUP9901065A3 HUP9901065A3 (en) | 2001-10-29 |
Family
ID=7781338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9901065A HUP9901065A3 (en) | 1995-12-23 | 1996-12-20 | New barbituric acid derivatives, pharmaceutical compositions containing these compounds and process for producing them |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6110924A (hu) |
| EP (1) | EP0869947B1 (hu) |
| JP (1) | JP4198752B2 (hu) |
| KR (1) | KR100440035B1 (hu) |
| CN (1) | CN1318406C (hu) |
| AT (1) | ATE226575T1 (hu) |
| BR (1) | BR9612232A (hu) |
| CZ (1) | CZ292503B6 (hu) |
| DE (2) | DE19548624A1 (hu) |
| DK (1) | DK0869947T3 (hu) |
| ES (1) | ES2184903T3 (hu) |
| HU (1) | HUP9901065A3 (hu) |
| IL (1) | IL125048A (hu) |
| MX (1) | MX9805063A (hu) |
| NO (1) | NO311572B1 (hu) |
| NZ (1) | NZ325802A (hu) |
| PL (1) | PL190217B1 (hu) |
| PT (1) | PT869947E (hu) |
| RU (1) | RU2177475C2 (hu) |
| TW (1) | TW518324B (hu) |
| WO (1) | WO1997023465A1 (hu) |
| ZA (1) | ZA9610765B (hu) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2247707T3 (es) | 1997-06-21 | 2006-03-01 | Roche Diagnostics Gmbh | Derivados del acido barbiturico con actividad antimetastasica y antitumoral. |
| DE19726427A1 (de) | 1997-06-23 | 1998-12-24 | Boehringer Mannheim Gmbh | Pyrimidin-2,4,6-trion-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| US6350786B1 (en) | 1998-09-22 | 2002-02-26 | Hoffmann-La Roche Inc. | Stable complexes of poorly soluble compounds in ionic polymers |
| US6265578B1 (en) * | 1999-02-12 | 2001-07-24 | Hoffmann-La Roche Inc. | Pyrimidine-2,4,6-triones |
| CO5210860A1 (es) * | 1999-10-01 | 2002-10-30 | Hoffmann La Roche | Nuevos derivados de pirimidina-2,4,6-triona |
| MXPA03003734A (es) | 2000-10-26 | 2003-07-28 | Pfizer Prod Inc | Inhibifores de metaloproteinasa del tipo pirimidin-2, 4, 6-triona. |
| US6716845B2 (en) | 2001-03-30 | 2004-04-06 | Hoffmann-La Roche Inc. | Barbituric acid derivatives |
| ATE344041T1 (de) * | 2001-05-03 | 2006-11-15 | Hoffmann La Roche | Kombination eines gelatinasehemmers und eines anti-tumor-agent, und deren verwendung |
| WO2002089743A2 (en) | 2001-05-09 | 2002-11-14 | The Regents Of The University Of Michigan | Use of compositions for treating rosacea |
| US6936620B2 (en) * | 2001-12-20 | 2005-08-30 | Bristol Myers Squibb Company | Barbituric acid derivatives as inhibitors of TNF-α converting enzyme (TACE) and/or matrix metalloproteinases |
| NI200300045A (es) * | 2002-04-26 | 2005-07-08 | Pfizer Prod Inc | Inhibidores de triariloxiariloxipirimidin-2,4,6-triona de metaloproteinasa. |
| JP2006516548A (ja) | 2002-12-30 | 2006-07-06 | アンジオテック インターナショナル アクツィエン ゲゼルシャフト | 迅速ゲル化ポリマー組成物からの薬物送達法 |
| WO2004084903A1 (en) * | 2003-03-27 | 2004-10-07 | F. Hoffmann-La Roche Ag | Use of a trioxopyrimidine for the treatment and prevention of ocular pathologic angiogenesis |
| WO2004084902A1 (en) * | 2003-03-28 | 2004-10-07 | F. Hoffmann-La Roche Ag | Use of a trioxopyrimidine for the treatment of chronic wounds |
| WO2004110457A1 (en) * | 2003-06-06 | 2004-12-23 | F. Hoffmann-La Roche Ag | Matrix metalloproteinases inhibitors for the stimulation and protection of bone marrow stem cells |
| JP4787240B2 (ja) * | 2004-04-01 | 2011-10-05 | ユニベルシテ・ド・リエージュ | ピリミジン−２，４，６−トリオンのシクロデキストリン包接複合体 |
| WO2005097133A1 (en) * | 2004-04-01 | 2005-10-20 | F. Hoffmann-La Roche Ag | Use of a trioxopyrimidine for the treatment and prevention of bronchial inflammatory diseases |
| EP1632489A1 (en) * | 2004-08-24 | 2006-03-08 | University of Liege | 5-(1,1'-Biphenyl)-4-yl-5-(4-(4-aminoacylphenyl)-piperazin)-1-yl-pyrimidine-2,4,6-trione derivatives, as inhibitors of zinc metallondopeptidases, their preparation and use. |
| CN102234249B (zh) * | 2010-04-23 | 2013-08-28 | 首都医科大学 | N-(六氢嘧啶-1,3-二基)-二-l-氨基酸甲酯及其制备方法和应用 |
| NZ604035A (en) | 2010-06-04 | 2015-02-27 | Albany Molecular Res Inc | Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
| KR101822417B1 (ko) * | 2017-06-14 | 2018-01-29 | 주식회사 청도제약 | 인간의 체액에서 산화 스트레스를 측정하기 위한 방법 |
| KR102432016B1 (ko) | 2020-07-31 | 2022-08-16 | 부산대학교 산학협력단 | 신경염증질환 예방 또는 치료용 조성물 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2078323A (en) * | 1937-04-27 | C-amino-substituted barbituric | ||
| US2084136A (en) * | 1933-06-03 | 1937-06-15 | Heyden Chem Fab | Barbituric acid containing in the 5-position a pyridine group and method of preparing the same |
| DE763145C (de) * | 1942-05-29 | 1954-05-03 | Chem Fab Von Heyden A G | Verfahren zur Herstellung von 5-AEthyl-5-piperidinobarbitursaeure |
| US3930006A (en) * | 1963-04-30 | 1975-12-30 | Aspro Nicholas Ltd | Antiparkinsonism compositions and method |
| DE1246743B (de) * | 1965-01-12 | 1967-08-10 | Dresden Arzneimittel | Verfahren zur Herstellung von 5-Phenyl-5-piperidinobarbitursaeuren |
| DE19726427A1 (de) * | 1997-06-23 | 1998-12-24 | Boehringer Mannheim Gmbh | Pyrimidin-2,4,6-trion-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
-
1995
- 1995-12-23 DE DE19548624A patent/DE19548624A1/de not_active Withdrawn
-
1996
- 1996-12-20 ES ES96944612T patent/ES2184903T3/es not_active Expired - Lifetime
- 1996-12-20 NZ NZ325802A patent/NZ325802A/xx unknown
- 1996-12-20 WO PCT/EP1996/005766 patent/WO1997023465A1/en active IP Right Grant
- 1996-12-20 ZA ZA9610765A patent/ZA9610765B/xx unknown
- 1996-12-20 PL PL96327466A patent/PL190217B1/pl not_active IP Right Cessation
- 1996-12-20 DK DK96944612T patent/DK0869947T3/da active
- 1996-12-20 DE DE69624500T patent/DE69624500T2/de not_active Expired - Fee Related
- 1996-12-20 KR KR10-1998-0704855A patent/KR100440035B1/ko not_active IP Right Cessation
- 1996-12-20 BR BR9612232A patent/BR9612232A/pt not_active IP Right Cessation
- 1996-12-20 AT AT96944612T patent/ATE226575T1/de not_active IP Right Cessation
- 1996-12-20 PT PT96944612T patent/PT869947E/pt unknown
- 1996-12-20 EP EP96944612A patent/EP0869947B1/en not_active Expired - Lifetime
- 1996-12-20 IL IL12504896A patent/IL125048A/en not_active IP Right Cessation
- 1996-12-20 CZ CZ19981968A patent/CZ292503B6/cs not_active IP Right Cessation
- 1996-12-20 RU RU98113916/04A patent/RU2177475C2/ru not_active IP Right Cessation
- 1996-12-20 JP JP52331897A patent/JP4198752B2/ja not_active Expired - Fee Related
- 1996-12-20 HU HU9901065A patent/HUP9901065A3/hu unknown
- 1996-12-20 CN CNB961800275A patent/CN1318406C/zh not_active Expired - Fee Related
- 1996-12-20 US US09/091,352 patent/US6110924A/en not_active Expired - Fee Related
-
1997
- 1997-01-28 TW TW086101091A patent/TW518324B/zh not_active IP Right Cessation
-
1998
- 1998-06-22 MX MX9805063A patent/MX9805063A/es not_active IP Right Cessation
- 1998-06-22 NO NO19982901A patent/NO311572B1/no unknown
-
2000
- 2000-06-16 US US09/594,700 patent/US6472396B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9901065A2 (hu) | Új barbitursavszármazékok, ezen vegyületeket tartalmazó gyógyászati készítmények és eljárás előállításukra | |
| ES2012927A6 (es) | Procedimiento para preparar derivados de adenosina. | |
| HUP0004529A2 (hu) | VLA-4 által mediált leukocita adhéziót gátló szulfonilezett dipeptid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint alkalmazásuk | |
| HK18596A (en) | Tricyclo compounds a process for their production and a pharmaceutical composition containing the same | |
| NO179675C (no) | Pyrimidin-nukleosidderivater og farmasöytisk preparat inneholdende disse | |
| HUP9802865A2 (hu) | N-(szubsztituált fenil-)-pirazol-származékok, előállításuk és alkalmazásuk, a vegyületeket hatóanyagként tartalmazó parazitaellenes készítmények | |
| HUP0004226A2 (hu) | Új D-vitamin-analógok, ezeket tartalmazó gyógyászati készítmény és eljárás előállításukra | |
| HU9400250D0 (en) | Quinoline-or quinazoine derivatives process fop producing them and pharmaceutical compositions containing them | |
| HUP9904392A2 (hu) | Új eritromicinszármazékok, eljárás előállításukra, és gyógyszerkénti alkalmazásuk | |
| ES8500893A1 (es) | Procedimiento para preparar acilanilidas. | |
| KR860001819A (ko) | 티아(옥사)디아졸 유도체의 제조방법 | |
| TW362954B (en) | Stabilized composition, method for using said composition, and medium containing said | |
| TW259785B (en) | Chemical compounds | |
| ES470738A1 (es) | Procedimiento para la obtencion de nuevos derivados de ni- trosourea | |
| ES8701174A1 (es) | Un metodo de preparacion de un compuesto de tiadiazina | |
| GB1215367A (en) | Pesticidal phosphonoacetylhydrazides | |
| CA1273946C (en) | ANTICONVULSANT GAMMA-THIOBUTYROLACTONE DERIVATIVES | |
| ES475588A1 (es) | Procedimiento para la obtencion de derivados del acido inde-no -2,1-b- tiofen-2-oxamico | |
| HUP0000275A2 (hu) | Fenantridiniumszármazékok, valamint ezeket a vegyületeket tartalmazó gyógyászati készítmények | |
| HUP0003059A2 (hu) | Eljárás 2-alkiltiobenzoesav-származékok előállítására | |
| ES8307246A1 (es) | "procedimiento de preparacion de nuevos compuestos de lactama". | |
| IE43602L (en) | Benzocycloheptathiophenes | |
| GR3021336T3 (en) | New process for the preparation of 20-oxo, 17-alpha, 21-dihydroxy derivatives of pregnane and new intermediates thereof. | |
| GB1221389A (en) | 2,4-dicyano-6-nitrobenzene derivatives | |
| HUP0003321A2 (hu) | Eljárás 2-alkiltiobenzonitril-származékok előállítására |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |